Literature DB >> 16085716

Effects of simvastatin within two weeks on anti-inflammatory cytokine interleukin 10 in patients with unstable angina.

J-J Li, Y-S Li, C-H Fang, R-T Hui, Y-J Yang, J-L Cheng, R-L Gao.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16085716      PMCID： PMC1860880          DOI： 10.1136/hrt.2004.057489

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  6 in total

1.  Enhanced inflammatory response of blood monocytes to C-reactive protein in patients with unstable angina.

Authors:  Jian-Jun Li; Hai-Rong Wang; Cong-Xin Huang; Jia-Lin Xue; Geng-Shan Li
Journal:  Clin Chim Acta       Date:  2005-02       Impact factor: 3.786

2.  Serum level of the antiinflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes.

Authors:  Christopher Heeschen; Stefanie Dimmeler; Christian W Hamm; Stephan Fichtlscherer; Eric Boersma; Maarten L Simoons; Andreas M Zeiher
Journal:  Circulation       Date:  2003-03-31       Impact factor: 29.690

3.  Activation of nuclear factor-kappaB and correlation with elevated plasma c-reactive protein in patients with unstable angina.

Authors:  Jian-Jun Li; Chun-Hong Fang; Ming-Zhe Chen; Xin Chen; Stephen W L Lee
Journal:  Heart Lung Circ       Date:  2004-06       Impact factor: 2.975

4.  Serum tumour necrosis factor-alpha, interleukin-2 and interleukin-10 activation in stable angina and acute coronary syndromes.

Authors:  Katarzyna Mizia-Stec; Zbigniew Gasior; Barbara Zahorska-Markiewicz; Joanna Janowska; Andrzej Szulc; Ewa Jastrzebska-Maj; Iwona Kobielusz-Gembala
Journal:  Coron Artery Dis       Date:  2003-09       Impact factor: 1.439

5.  Interleukin-10 serum levels and systemic endothelial vasoreactivity in patients with coronary artery disease.

Authors:  Stephan Fichtlscherer; Susanne Breuer; Christopher Heeschen; Stefanie Dimmeler; Andreas M Zeiher
Journal:  J Am Coll Cardiol       Date:  2004-07-07       Impact factor: 24.094

Review 6.  Cytokine imbalance in acute coronary syndrome.

Authors:  Samir E Alam; Samer S Nasser; Khaled E Fernainy; Aida A Habib; Kamal F Badr
Journal:  Curr Opin Pharmacol       Date:  2004-04       Impact factor: 5.547
  6 in total
  6 in total

1.  In vivo transmigrated monocytes from patients with stable coronary artery disease have a reduced expression of CD11b.

Authors:  J M Paulsson; E Dadfar; C Held; S H Jacobson; J Lundahl
Journal:  Clin Exp Immunol       Date:  2008-05-05       Impact factor: 4.330

2.  Effects of Wenxiao Decoction on the expression of interleukin-6, intercellular adhesion molecular-1 and monocyte chemoattractant protein-1 in experimental atherosclerotic rabbits.

Authors:  Qing-ping Huo; Fang Liang; Jin-pu Li; Yu-xin Wang; Han-yan Liu
Journal:  Chin J Integr Med       Date:  2013-11-16       Impact factor: 1.978

3.  Enhanced pro-protein convertase subtilisin/kexin type 9 expression by C-reactive protein through p38MAPK-HNF1α pathway in HepG2 cells.

Authors:  Chuan-Jue Cui; Sha Li; Cheng-Gang Zhu; Jing Sun; Ying Du; Yan Zhang; Na-Qiong Wu; Yuan-Lin Guo; Rui-Xia Xu; Ying Gao; Jian-Jun Li
Journal:  J Cell Mol Med       Date:  2016-09-15       Impact factor: 5.310

4.  Atorvastatin inhibits the immediate-early response gene EGR1 and improves the functional profile of CD4+T-lymphocytes in acute coronary syndromes.

Authors:  Anna Severino; Chiara Zara; Mara Campioni; Davide Flego; Giulia Angelini; Daniela Pedicino; Ada Francesca Giglio; Francesco Trotta; Simona Giubilato; Vincenzo Pazzano; Claudia Lucci; Antonio Iaconelli; Aureliano Ruggio; Luigi Marzio Biasucci; Filippo Crea; Giovanna Liuzzo
Journal:  Oncotarget       Date:  2017-03-14

5.  Relation of plasma PCSK9 levels to lipoprotein subfractions in patients with stable coronary artery disease.

Authors:  Rui-Xia Xu; Sha Li; Yan Zhang; Xiao-Lin Li; Yuan-Lin Guo; Cheng-Gang Zhu; Jian-Jun Li
Journal:  Lipids Health Dis       Date:  2014-12-11       Impact factor: 3.876

6.  Impact of PCSK9 monoclonal antibodies on circulating hs-CRP levels: a systematic review and meta-analysis of randomised controlled trials.

Authors:  Ye-Xuan Cao; Sha Li; Hui-Hui Liu; Jian-Jun Li
Journal:  BMJ Open       Date:  2018-10-04       Impact factor: 2.692
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.